Introduction Oesophageal and gastric cancers remain poor prognosis cancers with a recommended outcome from MDT as stent only for palliation. This study addresses factors that may affect survival in this group.

Method For the 5 year period 2009–13, all patients that had MDT outcome from our regional oesophago-gastric MDT of stent only for palliative treatment were collated. Clinical and pathological data was obtained from the electronic clinical record and survival was calculated. Survivals were compared by Kaplan-Meier log rank analysis using SPSS.

Results Two-hundred and seventeen patients had MDT recommendation of stent only from MDT in the study period and median survival was 76 days from diagnosis. Factors significantly affecting survival were presence or absence of metastatic disease, low neutrophil lymphocyte ratio (NLR) and low modified Glasgow Prognostic Score (mGPS).

Conclusion MDT decision making appears good at selecting poor prognosis patients for stent only, however within this group the prognostic factors based on systemic inflammation (NLR and mGPS) can select out a subgroup of patient with a median survival of over 150 days that may benefit from consideration of additional treatment.

Disclosure of interest None Declared.